Quarterly report pursuant to Section 13 or 15(d)

Net Loss per Common Share (Tables)

v3.24.1.1.u2
Net Loss per Common Share (Tables)
3 Months Ended
Mar. 31, 2024
Net Loss per Common Share  
Schedule of Diluted Weighted Average Shares Outstanding

​

​

​

​

​

​

​

    

​

​

​

Three Months Ended March 31, 

​

​

2024

    

2023

Warrants to purchase Common Stock

 

5,769,788

 

127,296

Options to purchase Common Stock

 

18,896

 

41,508

Unvested Restricted Stock

 

1,725,726

 

1,379,934

Unvested Restricted Stock Units

 

1,267

 

71

Total

 

7,515,677

 

1,548,809

​